Ms Vivian Lee

Senior Research Scientist, Protein Therapeutics at Gilead Sciences

Speaker

Vivian Lee has over 20 years drug development experiences in biotech/pharmaceutical industry including Onyx Pharmaceuticals, Genentech and 23andme. She has established human synthetic antibody phage libraries, a two in one antibody technology, T-cell engager platforms and lead optimization strategies. She currently works as Senior Research Scientist in Protein Therapeutics Department at Gilead Sciences, leading biologics discovery in various therapeutic areas including oncology, inflammation and virology.